Klara Lenart

About me
Publications
CV
Public outreach and news

About me

Klara has a Bachelor of Science in Biochemistry from University of Ljubljana, Slovenia, and a Master of Medical Science in Biomedicine from Karolinska Institutet, Stockholm. She joined our group in 2019 for a master thesis project, and was later selected for a KID-funded position to perform her PhD studies.

Articles

Article: NPJ VACCINES. 2024;9(1):17

Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2.

Lenart K; Arcoverde Cerveira R; Hellgren F; Ols S; Sheward DJ; Kim C; Cagigi A; Gagne M; Davis B; Germosen D; Roy V; Alter G; Letscher H; Van Wassenhove J; Gros W; Gallouët A-S; Le Grand R; Kleanthous H; Guebre-Xabier M; Murrell B; Patel N; Glenn G; Smith G; Loré K
Article: IMMUNITY. 2023;56(10):2425-2441.e14

Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses.

Ols S; Lenart K; Arcoverde Cerveira R; Miranda MC; Brunette N; Kochmann J; Corcoran M; Skotheim R; Philomin A; Cagigi A; Fiala B; Wrenn S; Marcandalli J; Hellgren F; Thompson EA; Lin A; Gegenfurtner F; Kumar A; Chen M; Phad GE; Graham BS; Perez L; Borst AJ; Karlsson Hedestam GB; Ruckwardt TJ; King NP; Loré K
Article: CELLULAR AND MOLECULAR LIFE SCIENCES. 2023;80(7):189

Cell targeting and immunostimulatory properties of a novel Fcγ-receptor-independent agonistic anti-CD40 antibody in rhesus macaques.

Yan X; Ols S; Arcoverde Cerveira R; Lenart K; Hellgren F; Ye K; Cagigi A; Buggert M; Nimmerjahn F; Falkesgaard Højen J; Parera D; Pessara U; Fischer S; Loré K
Article: NATURE COMMUNICATIONS. 2023;14(1):2164

Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19.

Yu M; Charles A; Cagigi A; Christ W; Österberg B; Falck-Jones S; Azizmohammadi L; Åhlberg E; Falck-Jones R; Svensson J; Nie M; Warnqvist A; Hellgren F; Lenart K; Arcoverde Cerveira R; Ols S; Lindgren G; Lin A; Maecker H; Bell M; Johansson N; Albert J; Sundling C; Czarnewski P; Klingström J; Färnert A; Loré K; Smed-Sörensen A
Article: MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT. 2022;27:309-323

A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses.

Lenart K; Hellgren F; Ols S; Yan X; Cagigi A; Cerveira RA; Winge I; Hanczak J; Mueller SO; Jasny E; Schwendt K; Rauch S; Petsch B; Loré K
Article: JCI INSIGHT. 2021;6(22):e151463

Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination.

Cagigi A; Yu M; Österberg B; Svensson J; Falck-Jones S; Vangeti S; Åhlberg E; Azizmohammadi L; Warnqvist A; Falck-Jones R; Gubisch PC; Ödemis M; Ghafoor F; Eisele M; Lenart K; Bell M; Johansson N; Albert J; Sälde J; Pettie DD; Murphy MP; Carter L; King NP; Ols S; Normark J; Ahlm C; Forsell MN; Färnert A; Loré K; Smed-Sörensen A
Article: CELL REPORTS MEDICINE. 2021;2(4):100252

SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses.

Mandolesi M; Sheward DJ; Hanke L; Ma J; Pushparaj P; Perez Vidakovics L; Kim C; Àdori M; Lenart K; Loré K; Castro Dopico X; Coquet JM; McInerney GM; Karlsson Hedestam GB; Murrell B
Article: JOURNAL OF CLINICAL INVESTIGATION. 2021;131(6):144734

Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity.

Falck-Jones S; Vangeti S; Yu M; Falck-Jones R; Cagigi A; Badolati I; Österberg B; Lautenbach MJ; Åhlberg E; Lin A; Lepzien R; Szurgot I; Lenart K; Hellgren F; Maecker H; Sälde J; Albert J; Johansson N; Bell M; Loré K; Färnert A; Smed-Sörensen A

About me

Articles

Employments

Degrees and Education

News from KI

Events from KI